Перейти к главному меню навигации Перейти к основному контенту Перейти к нижнему колонтитулу сайта

ВИДЕО КОНТРОЛИРУЕМОЕ ЛЕЧЕНИЕ БОЛЬ- НЫХ РЕЗИСТЕНТНЫМ ТУБЕРКУЛЁЗОМ

Организация
Samarkand State Medical Institute image/svg+xml

Аннотация

To evaluate the significance of video controlled therapy (VCT) for optimization of treatment approaches for patients with multidrug-resistant and extensively drug-resistant tuberculosis (MDR/XDR-TB) by creating favorable conditions for improving quality of life and increasing loyalty to chemotherapy. . The category of patients is persons treated with anti-TB drugs, regardless of the type of tolerance and stage of treatment. All requirements for the organization of video-controlled treatment in outpatient conditions according to the instructions were fulfilled. Monitoring was conducted remotely online, daily by a specialist of the institution and monthly by the regional coordinator, using special report forms and a specialized application. The results of our case study showed that VKL and psycho-social support of the patient (PPSP) resulted in 85% cure rate, compared to 72% in patients with traditional treatment method. VCL allows PPSP and reduction of patient's anxiety about confidentiality, which increases adherence to treatment. Patients were recruited into the program based on their consent. There is an opportunity to administer a large number of antimicrobial drugs (AMBs) in a day (2-3 times), with timely response and elimination of adverse drug reactions (ADRs) in the patient by the coordinating physician. Simultaneous dispensing of medicines for 15 days saves time and opportunities for self-realization of the patient. Problems with costs of treatment organization and irrational distribution of resources in health care are solved.

Библиографические ссылки

  1. Thirteenth General Program of Work for 2019–2023: strengthening health, maintaining global se- curity, and reaching vulnerable populations. Geneva: WHO; 2019 (https://apps.who.int/iris/han- dle/10665/328844, accessed on 11 July 2020)
  2. European Programme of Work for 2020–2025: Working together to improve the health of people in Europe . Copenhagen: WHO Regional Office for Europe; 2020 (https://apps.who.int/iris/bit- stream/handle/10665/333909/70wd11r-rev4-EPW-200673.pdf, accessed on September 30, 2020)
  3. Decree of the President of the Republic of Uzbekistan dated February 13, 2019. PP-4191 “On measures to improve the system of providing specialized phthisiatric and pulmonological care,” https://lex.uz/docs/4201086
  4. Decree of the President of the Republic of Uzbekistan No. UP-6079 of October 5, 2020, “On the approval of the strategy ‘Digital Uzbekistan-2030’ and measures for its effective implementation,” https://lex.uz/docs/5031048
  5. Brief guide to video support in the treatment of tuberculosis, WHO, 2020 https://www.euro.who.int/ru/publications/abstracts/quick-guide-to-video-supported-treatment-of-tu- berculosis-2020
  6. Consolidated guidelines for the treatment of drug-resistant tuberculosis, WHO, 2020 https://apps.who.int/iris/handle/10665/329298
  7. Law of the Republic of Uzbekistan No. ZRU-547 “On Personal Data,” adopted by the Legislative Chamber on April 16, 2019, and approved by the Senate on June 21, 2019, https://lex.uz/docs/4396428
  8. Law of the Republic of Uzbekistan No. 215-II “On the Protection of the Population from Tuber- culosis” dated May 11, 2001. https://lex.uz/docs/4888
  9. National Clinical Protocol for the Management of Adult Patients with Respiratory Tuberculosis, NCP No. 1 of February 14, 2020

Скачивания

Данные скачивания пока недоступны.